Apotex Health Corp. (TSX: APTX)
Health Care · Pharmaceuticals · CA
CA$34.15
-8.64% today · +26.5% 1Y
Apotex Health Corp. (TSX: APTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.62B and employs 6,216 people.
Over the last twelve months the share price has gained 26.5%, trading between 26.05 and 40.18.
Tweenvest scores Apotex Health Corp. across four factors: dividend 0/100. Its strongest factor is dividend.
APTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.62B
- Revenue (TTM)
- $2.25B
- P/E
- —
- EPS
- 1.91
- Dividend yield
- 0.59%
- Beta (5Y)
- —
- 52-week high
- CA$40.18
- 52-week low
- CA$26.05
- Avg volume (3M)
- —
- Shares outstanding
- 228.50M
- Employees
- 6,216
- Next earnings
- —
About Apotex Health Corp.
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
- ISIN
- CA03772D1015
- Founded
- 1974
- Listed since
- Jun 11, 2026
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.80 | +0.11% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.